// STATE LEGISLATION TRACKER

Minnesota SF 4486: Pharmacists authorization to initiate, prescribe, administer, and dispense certain drugs for the treatment of opioid use

⚖️ NEUTRAL for peptide users 👤 LOW user impact 📜 Status: In committee

State: Minnesota
Bill: SF 4486
Session: 2025-2026
Filed: 2026-03-17
Read the bill: OpenStates →
Last reviewed: 2026-10-05

Plain-English Summary

Minnesota SF4486 authorizes pharmacists to initiate, prescribe, administer, and dispense certain drugs for the treatment of opioid use disorder. This bill aims to increase access to essential medications for opioid use disorder by leveraging the accessibility of pharmacists, especially in underserved areas.

Key Points

Pharmacists can now prescribe and dispense medications for opioid use disorder.
Requires pharmacists to complete specific training before prescribing.
Aims to reduce treatment wait times for opioid use disorder.
Expands access to medications like buprenorphine.
Pharmacist interns can assist but an authorized pharmacist must sign prescriptions.

What to Watch For

✓

Opportunity Increased access to MOUD through pharmacies, potentially benefiting patients who have difficulty accessing traditional healthcare providers.

Concern Potential for increased scrutiny on pharmacist prescribing practices, especially for controlled substances.

Note Bill focuses specifically on opioid use disorder treatment, not general peptide prescribing.

Where the Bill Stands

The bill has been introduced and referred to the Health and Human Services Committee.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-10-05 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws